Literature DB >> 24090364

Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y(4) receptor.

Lukasz Berlicki1, Melanie Kaske, Raquel Gutiérrez-Abad, Günther Bernhardt, Ona Illa, Rosa M Ortuño, Chiara Cabrele, Armin Buschauer, Oliver Reiser.   

Abstract

Neuropeptide Y (NPY) and pancreatic polypeptide (PP) control central and peripheral processes by activating the G protein coupled receptors YxR (x = 1, 2, 4, 5). We present analogs of the C-terminal fragments 25-36 and 32-36 of NPY and PP containing (1R,2S)-cyclobutane (βCbu) or (1R,2S)-cyclopentane (βCpe) β-amino acids, which display exclusively Y4R affinity. In particular, [βCpe(34)]-NPY-(25-36) is a Y4R selective partial agonist (EC50 41 ± 6 nM, Emax 71%) that binds Y4R with a Ki of 10 ± 2 nM and a selectivity >100-fold relative to Y1R and Y2R and >50-fold relative to Y5R. Comparably, [Y(32), βCpe(34)]-NPY(PP)-(32-36) selectively binds and activates Y4R (EC50 94 ± 21 nM, Emax 73%). The NMR structure of [βCpe(34)]-NPY-(25-36) in dodecylphosphatidylcholine micelles shows a short helix at residues 27-32, while the C-terminal segment R(33)βCpe(34)R(35)Y(36) is extended. The biological properties of the βCbu- or βCpe-containing NPY and PP C-terminal fragments encourage the future application of these β-amino acids in the synthesis of selective Y4R ligands.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24090364     DOI: 10.1021/jm4008505

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Receptor selectivity from minimal backbone modification of a polypeptide agonist.

Authors:  Shi Liu; Ross W Cheloha; Tomoyuki Watanabe; Thomas J Gardella; Samuel H Gellman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-15       Impact factor: 11.205

Review 2.  Folding and function in α/β-peptides: targets and therapeutic applications.

Authors:  Halina M Werner; W Seth Horne
Journal:  Curr Opin Chem Biol       Date:  2015-06-30       Impact factor: 8.822

3.  Synthesis of 1,3-Substituted Cyclobutanes by Allenoate-Alkene [2 + 2] Cycloaddition.

Authors:  Michael L Conner; M Kevin Brown
Journal:  J Org Chem       Date:  2016-08-25       Impact factor: 4.354

4.  Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes.

Authors:  Ruslan Gibadullin; Caleb J Randall; John Sidney; Alessandro Sette; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2021-04-21       Impact factor: 15.419

5.  A Short-Length Peptide YY Analogue with Anorectic Effect in Mice.

Authors:  Naoki Nishizawa; Ayumu Niida; Yasushi Masuda; Satoshi Kumano; Kotaro Yokoyama; Hideki Hirabayashi; Nobuyuki Amano; Tetsuya Ohtaki; Taiji Asami
Journal:  ACS Omega       Date:  2017-05-18

6.  In Search of NPY Y4R Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.

Authors:  Kilian K Kuhn; Timo Littmann; Stefanie Dukorn; Miho Tanaka; Max Keller; Takeaki Ozawa; Günther Bernhardt; Armin Buschauer
Journal:  ACS Omega       Date:  2017-07-14

7.  Cyclobutane-Containing Scaffolds as Useful Intermediates in the Stereoselective Synthesis of Suitable Candidates for Biomedical Purposes: Surfactants, Gelators and Metal Cation Ligands.

Authors:  Ona Illa; Albert Serra; Agustí Ardiaca; Xavier Herrero; Guillem Closa; Rosa M Ortuño
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

8.  Controlling the conformational stability of coiled-coil peptides with a single stereogenic center of a peripheral β-amino acid residue.

Authors:  Monika Szefczyk; Katarzyna Ożga; Magda Drewniak-Świtalska; Ewa Rudzińska-Szostak; Rafał Hołubowicz; Andrzej Ożyhar; Łukasz Berlicki
Journal:  RSC Adv       Date:  2022-02-07       Impact factor: 3.361

Review 9.  Cyclobutanes in Small-Molecule Drug Candidates.

Authors:  Marnix R van der Kolk; Mathilde A C H Janssen; Floris P J T Rutjes; Daniel Blanco-Ania
Journal:  ChemMedChem       Date:  2022-03-29       Impact factor: 3.540

10.  Hybrid Cyclobutane/Proline-Containing Peptidomimetics: The Conformational Constraint Influences Their Cell-Penetration Ability.

Authors:  Ona Illa; Jimena Ospina; José-Emilio Sánchez-Aparicio; Ximena Pulido; María Ángeles Abengozar; Nerea Gaztelumendi; Daniel Carbajo; Carme Nogués; Luis Rivas; Jean-Didier Maréchal; Miriam Royo; Rosa M Ortuño
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.